136 related articles for article (PubMed ID: 34642066)
1. Curative-Intent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck in Sri Lanka: The Impact of Radiotherapy Technique on Survival.
Rupasinghe T; Silva DC; Balawardena J; Perera K; Gunasekera D; Weerasinghe S; Jeyakumaran N; Abeysinghe P; Skandarajah T; Choudhury A; Joseph N
Clin Oncol (R Coll Radiol); 2021 Dec; 33(12):765-772. PubMed ID: 34642066
[TBL] [Abstract][Full Text] [Related]
2. [Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].
Qian W; Zhu G; Ji Q; Guo Y; Wang Y; Wang Y
Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):217-22. PubMed ID: 24785284
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo Clinic.
Curtis KK; Ross HJ; Garrett AL; Jizba TA; Patel AB; Patel SH; Wong WW; Halyard MY; Ko SJ; Kosiorek HE; Foote RL
Radiat Oncol; 2016 Apr; 11():55. PubMed ID: 27061083
[TBL] [Abstract][Full Text] [Related]
4. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
5. Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.
Refaat T; Choi M; Thomas TO; Bacchus I; Agulnik M; Pelzer HJ; Mellott AL; Rademaker AW; Liu D; Sathiaseelan V; Mittal BB
Am J Clin Oncol; 2015 Dec; 38(6):588-94. PubMed ID: 24136140
[TBL] [Abstract][Full Text] [Related]
6. Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy.
Yao M; Lu M; Savvides PS; Rezaee R; Zender CA; Lavertu P; Buatti JM; Machtay M
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):684-9. PubMed ID: 22169673
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity.
Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
Radiat Oncol; 2017 Aug; 12(1):131. PubMed ID: 28810885
[TBL] [Abstract][Full Text] [Related]
8. Systematic review and meta-analyses of intensity-modulated radiation therapy versus conventional two-dimensional and/or or three-dimensional radiotherapy in curative-intent management of head and neck squamous cell carcinoma.
Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
PLoS One; 2018; 13(7):e0200137. PubMed ID: 29979726
[TBL] [Abstract][Full Text] [Related]
9. Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses.
Takiar V; Garden AS; Ma D; Morrison WH; Edson M; Zafereo ME; Gunn GB; Fuller CD; Beadle B; Frank SJ; William WN; Kies M; El-Naggar AK; Weber R; Rosenthal DI; Phan J
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1117-31. PubMed ID: 27354127
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of intensity-modulated radiotherapy versus conventional radiotherapy for hypopharyngeal cancer.
Mok G; Gauthier I; Jiang H; Huang SH; Chan K; Witterick IJ; O'Sullivan B; Waldron JN; Bayley AJ; Cho BC; Cummings BJ; Dawson LA; Hope AJ; Kim JJ; Ringash J
Head Neck; 2015 May; 37(5):655-61. PubMed ID: 24590756
[TBL] [Abstract][Full Text] [Related]
11. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
[TBL] [Abstract][Full Text] [Related]
12. Hypopharyngeal squamous cell carcinoma: Three-dimensional or Intensity-modulated radiotherapy? A single institution's experience.
Katsoulakis E; Riaz N; Hu M; Morris L; Sherman E; McBride S; Lee N
Laryngoscope; 2016 Mar; 126(3):620-6. PubMed ID: 26597398
[TBL] [Abstract][Full Text] [Related]
13. Costs of care in a matched pair comparison of intensity-modulated radiation therapy (IMRT) versus conventional radiation therapy (CRT) for the treatment of head and neck cancer.
Sheets NC; Wheeler SB; Kohler RE; Fried DV; Brown PM; Chera BS
Am J Clin Oncol; 2014 Dec; 37(6):539-44. PubMed ID: 23466583
[TBL] [Abstract][Full Text] [Related]
14. Implementation of intensity-modulated radiotherapy for head and neck cancers in routine practice.
Bednarek C; Nguyen TV; Puyraveau M; Bonnet É; Lescut N; Azélie C; Miny J; Mauvais O; Maurina T; Tochet F; Bosset JF; Thariat J; Sun XS
Cancer Radiother; 2017 Feb; 21(1):21-27. PubMed ID: 28034680
[TBL] [Abstract][Full Text] [Related]
15. Use of a conventional low neck field (LNF) and intensity-modulated radiotherapy (IMRT): no clinical detriment of IMRT to an anterior LNF during the treatment of head-and neck-cancer.
Turaka A; Li T; Nicolaou N; Lango MN; Burtness B; Horwitz EM; Ridge JA; Feigenberg SJ
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):65-70. PubMed ID: 20385457
[TBL] [Abstract][Full Text] [Related]
16. Cervical lymph node metastases from unknown primary cancer: a single-institution experience with intensity-modulated radiotherapy.
Villeneuve H; Després P; Fortin B; Filion E; Donath D; Soulières D; Guertin L; Ayad T; Christopoulos A; Nguyen-Tan PF
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1866-71. PubMed ID: 21497452
[TBL] [Abstract][Full Text] [Related]
17. Tumour volume and radiotherapy prolongation in locally advanced head and neck cancer patients treated with radical IMRT.
Lohynska R; Jirkovska M; Malinova B; Novakova-Jiresova A; Pechacova Z; Kratka Z
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2022 Dec; 166(4):405-411. PubMed ID: 34498610
[TBL] [Abstract][Full Text] [Related]
18. Total Mucosal Irradiation with Intensity-modulated Radiotherapy in Patients with Head and Neck Carcinoma of Unknown Primary: A Pooled Analysis of Two Prospective Studies.
Richards TM; Bhide SA; Miah AB; Del Rosario L; Bodla S; Thway K; Gujral DM; Rooney KP; Schick U; McGovern T; Grove L; Newbold KL; Harrington KJ; Nutting CM
Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):e77-e84. PubMed ID: 27180092
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of intensity-modulated radiotherapy combined with chemotherapy or surgery in locally advanced squamous cell carcinoma of the head-and-neck.
Yang H; Diao LQ; Shi M; Ma R; Wang JH; Li JP; Xiao F; Xue Y; Xu M; Zhou B
Biologics; 2013; 7():223-9. PubMed ID: 24204121
[TBL] [Abstract][Full Text] [Related]
20. Determining priority risk groups for compensation of treatment breaks in radical radiotherapy in patients with locally advanced head and neck cancer.
Lohynska R; Jirkovska M; Novakova-Jiresova A; Kratka Z; Malinova B
J BUON; 2021; 26(3):792-801. PubMed ID: 34268938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
